Palliative radionuclide therapy for painful bone metastases by means of 186Rhenium-HEDP

Abstract

In this article are presented results of the 186Rhenium-HEDP systemic radionuclide treatment in patients with hormone-refractory prostate cancer or breast cancer and painful bone metastases.

Keywords

• Bone pain
• Breast cancer-bone metastases
• Prostate cancer
• 186Rhenium-HEDP